Latest filing published 05 Aug 2026 for MBX Biosciences, Inc., €21k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Salomon Azoulay appears in our data through filings on MBX Biosciences, Inc. shares, published by SEC (Form 4). Between 2 February 2026 and 4 August 2026, the trades on record add up to 2 filings.
On the market, this insider has only sold: 1 sale, €21k in total. Outside the open market, there are 1 share grant.
Most recently, on 5 August 2026, the filings show an open-market sale worth €21k in MBX Biosciences, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations